Sign-Up for News
    -Click Here-

   SM Facebook 140x140

  SM Twitter 140x145

PARTNERSHIPS

  

  

  iConquerMS 141x35 small partner banner

   

  

 bionews services

 tannerlogo

 

 

Members

Reset Font Size

Search through our menus for many more articles, videos and presentations.

-----------------------------------------------------------

More Articles...

  1. 2017 - MS Symposium WEBINAR - Dec, 2nd
  2. Preliminary Results of MS Prevalence Study Estimate Nearly 1 Million Living with MS in the U.S.
  3. Repairing Damaged Tissues
  4. Pediatric MS Support
  5. 2017 - Pediatric MS Centers & Specialists - updated
  6. Multiple Sclerosis Risk Significantly Associated With Vitamin D Deficiency
  7. Ask the Expert: Managing Urinary Retention in Multiple Sclerosis
  8. This is a clinical trial for Patients with Urinary Incontinence, who have Multiple Sclerosis…
  9. ACCESS to CARE
  10. Multiple Sclerosis (MS) Treatment Options_Updated May 2017
  11. Considering OCREVUS for PPMS?
  12. Positive Phase III Results of Genentech’s Investigational Medicine Ocrevus™ (Ocrelizumab) Published in New England Journal of Medicine
  13. MAKE your Voice HEARD on MS Treatments
  14. Novartis Helps Raise Greater Awareness of Unique Challenges Faced by Women with MS
  15. Learn about Foot Drop - the cause, symptoms and treatments
  16. Navigate the #TSA checkpoint with #MS
  17. Multiple Sclerosis Patient Resources
  18. Disease Modifying Treatments for Multiple Sclerosis
  19. Possible JC Virus Vaccination Offers Important Implications for MS Treatment
  20. Stem cell news from Hadassah Hospital
  21. MS Views and News - Keeps You Up-to-date and Informed, Digitally
  22. Apr 16, 2015 - FDA approves Glatopa(TM) as the first generic competitor to MS therapy Copaxone® 20mg
  23. STATE of MS REPORT
  24. More Encouraging Results From Stem-Cell Transplants
  25. Multiple Sclerosis 101: Understanding the Nervous System
  26. Prescription Assistance Programs for MS Disease-Modifying Therapies
  27. More than 7,000 Scientists Present Findings at World’s Largest Gathering Dedicated to MS Research
  28. Teriflunomide Is Now the First Oral Regimen Proven to Delay Onset of Clinically Definite Multiple Sclerosis
  29. What Causes MS?
  30. Multiple Sclerosis (MS) SYMPTOMS - Learn to recognize and manage the possible symptoms of MS, which range from mild to severe.
  31. Nanotechnology a Possible Future Solution for Multiple Sclerosis
  32. Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute are one step closer to creating a viable cell replacement therapy for multiple sclerosis
  33. How multiple sclerosis is described and understood - redefined by an International committee
  34. Researchers Present Guide To Compassion Fatigue
  35. Multiple sclerosis discovery may explain gender gap

Upcoming Events

Dec
21

Dec 21 2017 6:15 pm - 8:45 pm

Dec
27

Dec 27 2017 6:30 pm - 8:00 pm

Jan
4

Jan 4 2018 6:00 pm - 7:30 pm

Feb
1

Feb 1 2018 6:00 pm - 7:30 pm

Feb
1

Feb 1 2018 9:20 pm - 11:20 pm

Feb
8

Feb 8 2018 6:30 pm - 8:30 pm

Feb
10

Feb 10 2018 11:00 am - 2:30 pm

Feb
22

Feb 22 2018 6:00 pm - 8:30 pm

Mar
20

Mar 20 2018 6:25 pm - 8:35 pm

MS Views and News Award Recipient

Donate & Support

Amount Tooltip $10.00
$25.00
$50.00
$100.00
$250.00
$500.00
$1,000.00
$
Payment method
top